“Developing an Effective Patenting Policy to Protect AI-Enabled Medical Devices”
October 7, 2024Marshall Gerstein Partner and patent attorney Ryan Phelan provides insight for medical device leaders as they embrace artificial intelligence (AI) to revolutionize the industry. In a column for Med Device Online, Ryan explores how to develop an effective patenting policy for protecting AI-powered medical devices, focusing on the FDA's evolving stance on patent eligibility and patent marking requirements.
“AI’s role in software-based medical devices, ranging from diagnostics to treatment plans, is rapidly growing,” Phelan notes. “As these innovations emerge, protecting intellectual property (IP), particularly through patents becomes critical. A well-defined AI policy is essential to safeguard these medical devices from infringement while encouraging further innovation.”
You may read Ryan’s article in Med Device Online here.